Skip to main content
Caplight Logo









RevitalVision

RevitalVision

Private
IsraelHealthcare & Life Scienceshttps://www.revitalvision.com/

Last Round

Grant

Aug 19, 2024

Total Funding Raised

$1.75M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

RevitalVision is a healthtech company that provides a SaaS-based digital training therapy technology designed for vision improvement.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Telemedicine, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

vision therapydigital therapeuticsamblyopia treatmentlazy eye treatmentneuroplasticityFDA clearedat-home vision therapyDTxperceptual learningpresbyopia treatmentvisual processingAI vision therapypost-LASIK vision improvementpost-cataract vision improvementCPT codessports vision trainingGabor patches

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RevitalVision Comparables

Compare RevitalVision with similar companies based on industry and business-model similarity.

RevitalVision comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CureSee
85%
Vivid Vision
85%
Hundred Vision
85%

RevitalVision Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 19, 2024
StrategicJan 1, 2024
AcceleratorNov 1, 2022
CrowdfundingMay 31, 2021
GrantAug 14, 2020

Key People

Founding team and executive leadership

Yair Yahav

Chief Executive Officer

Executive Team

RevitalVision Investors

Notable investors and investment history

RevitalVision investors
InvestorRounds
Israel Innovation AuthorityGrant
MATTERGrant
PipelBizCrowdfunding

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Monthly visitors increased 238% MoM, reaching 29.8K.

  • Mar 2, 2026

    Monthly visitors increased 36% MoM, reaching 11.2K.

RevitalVision Filings

Explore SEC and related filing metadata, where available.

RevitalVision filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about RevitalVision's valuation, stock price, and market status.

Is RevitalVision a public or private company?

RevitalVision is a private company.

What is the current stock price of RevitalVision?

RevitalVision is a private company with no public stock price. No recent secondary market data is available.

How much is RevitalVision worth (valuation)?

Valuation information for RevitalVision is not publicly available.

Can I buy RevitalVision stock?

RevitalVision shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was RevitalVision's last funding round?

Funding round information for RevitalVision is not publicly available.

Who are the main investors in RevitalVision?

Investor information for RevitalVision is not publicly disclosed.

Will RevitalVision IPO soon?

No public IPO plans have been announced for RevitalVision.

How can I track RevitalVision secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RevitalVision's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Employee Range16
Year Founded2019
Last FundingAug 19, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?